DOK6 and gastric cancer: Our results further suggest that the resulting decrease in DOK6 expression is not a bystander abnormality, as there were several significant molecular and clinical differences between the lowest and highest quartiles of DOK6-expressing gastric cancers, notably significantly longer survival associated with low DOK6 expression.